Balyasny Asset Management’s Select Medical SEM Stock Holding History

Balyasny Asset Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.8M	Buy	1,623,940 +719,203	+79%	+$11.9M	0.03%	591
2026 Q1	$14.7M	Buy	904,737 +848,246	+1,502%	+$13.3M	0.02%	829
2025 Q4	$839K	Buy	+56,491	New	+$798K	﹤0.01%	2271
2025 Q3	–	Sell	-16,849	Closed	-$256K	–	3412
2025 Q2	$256K	Buy	+16,849	New	+$263K	﹤0.01%	2528
2024 Q4	–	Sell	-172,669	Closed	-$3.24M	–	3208
2024 Q3	$3.24M	Buy	172,669 +159,167	+1,179%	+$3.05M	0.01%	1459
2024 Q2	$255K	Buy	+13,502	New	+$230K	﹤0.01%	2274
2023 Q4	–	Sell	-162,250	Closed	-$2.21M	–	2859
2023 Q3	$2.21M	Buy	+162,250	New	+$2.51M	﹤0.01%	1353
2023 Q2	–	Sell	-26,084	Closed	-$363K	–	2741
2023 Q1	$363K	Buy	+26,084	New	+$384K	﹤0.01%	2039
2022 Q4	–	Sell	-192,025	Closed	-$2.29M	–	3191
2022 Q3	$2.29M	Buy	192,025 +61,897	+48%	+$879K	0.01%	1427
2022 Q2	$1.66M	Sell	130,128 -10,317	-7%	-$132K	0.01%	1506
2022 Q1	$1.81M	Buy	140,445 +126,477	+905%	+$1.67M	0.01%	1416
2021 Q4	$221K	Sell	13,968 -9,035	-39%	-$154K	﹤0.01%	1814
2021 Q3	$448K	Buy	+23,003	New	+$457K	﹤0.01%	1508
2018 Q3	–	Sell	-25,973	Closed	-$254K	–	1994
2018 Q2	$254K	Buy	+25,973	New	+$255K	﹤0.01%	1572
2017 Q2	–	Sell	-19,490	Closed	-$140K	–	1706
2017 Q1	$140K	Sell	19,490 -59,102	-75%	-$428K	﹤0.01%	1501
2016 Q4	$561K	Buy	+78,592	New	+$547K	﹤0.01%	1124
2016 Q1	–	Sell	-415,618	Closed	-$2.67M	–	1501
2015 Q4	$2.67M	Buy	415,618 +353,442	+568%	+$2.21M	0.02%	616
2015 Q3	$361K	Buy	+62,176	New	+$461K	﹤0.01%	876

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Balyasny Asset Management's SEM Position: Q2 2026 in Review

Balyasny Asset Management increased its Select Medical (SEM) stake by 79% in Q2 2026, buying an estimated $11.9M and bringing the position to 1,623,940 shares worth $26.8M. The position accounts for 0.03% of the portfolio, ranked #591.

Balyasny Asset Management first reported a position in SEM in Q3 2015 and has held it in 18 quarters since. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Balyasny Asset Management held 1,623,940 shares of Select Medical worth $26.8M as of Q2 2026.
Balyasny Asset Management bought 719,203 Select Medical shares in Q2 2026, an estimated $11.9M.
Select Medical made up 0.03% of Balyasny Asset Management's portfolio in Q2 2026, its #591 holding.
Balyasny Asset Management first reported a position in Select Medical in Q3 2015 and has held it in 18 quarters since.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.